Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-037576

Options or other derivatives

  • Chief Legal Officer acquired 170,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Oltmans Curtis Gale · Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-02 Grant or award : show line 1 in the form Stock Option (right to buy) +170,000 170,000 D
Loading xslF345X05/ownership.xml…